TY  - RPRT
TI  - 53BP1 mediates sensitivity to chemotherapy and is associated with poor clinical outcomes in high-grade serous ovarian cancer
AU  - Skulimowski, M.
AU  - Bourbonnais, J.
AU  - Malaquin, N.
AU  - Fleury, H.
AU  - Clement, I.
AU  - Communal, L.
AU  - Rahimi, K.
AU  - Provencher, D.
AU  - Mes-Masson, A.-M.
AU  - Rodier, F.
PY  - 2023
DO  - 10.1101/2023.09.30.560286
UR  - https://www.biorxiv.org/content/10.1101/2023.09.30.560286v1
ID  - 10.1101/2023.09.30.560286
ER  -